Sonnet BioTherapeutics Holdings Inc SONN
NAS: SONN | ISIN: US83548R2040 30/04/2025
1,430 USD (+1,85%)
(+1,85%)
30/04/2025
Profiel Sonnet BioTherapeutics Holdings Inc
Website: www.chanticleerholdings.com
Hoofdzetel: Princeton, New Jersey 
Verenigde Staten
CEO: Michael Pruitt
Werknemers: 6